PPDI Beats Zacks Estimates
Pharmaceutical Product Development’s (NASDAQ:PPDI) second quarter 2010 earnings (excluding special items) of 23 cents per share surpassed the Zacks Consensus Estimate by 5 cents. On a reported basis, the company earned 18 cents per share as against 49 cents in the year-ago quarter. Earnings included income tax related charges of 3 cents per share resulting from ...
Recent Posts:
- Forex Meltdown - Review
- Financial Software Forex Trading
- You Can Get Basic Stock Option Trading Strategies And Tips
- Is Forex Trading Training Really So Important?
- Soft Dollar Zone: A Sensitive Area
- Bank of Canada: Key Interest Rate Raised by 0.25% to 1.0%
- Obama: US Economy is moving in the right direction
- RSI as a Forex Trend Indicator
- ECB raises eurozone growth forecasts and holds rates
- Dollar falls after US data; yen, franc under pressure
- Dollar Fades Even As Jobs Picture Brightens
- US unemployment edges up to 9.6%
- Experts see trouble ahead for developed world
- Canadian Dollar Jumps on US Nonfarm Payrolls
- Iceland Economy Contracted 8.4% Last Quarter
- Dollar loses the battle
- Too Early to `Declare Victory' as Housing Revives
- Dollar down against euro, up against yen
- Technical Analysis, September 6th September 10th, 2010
- Are the USD & EUR to be Dance Partners in Lieu of Growth?